非高密度脂蛋白联合碱性磷酸酶在老年体检人群动脉粥样硬化风险评估的价值
2017-11-14张丽芬余冰冰钟毓瑜
张丽芬 余冰冰 钟毓瑜

【摘要】 目的:探討非高密度脂蛋白(non-HDL-C)联合碱性磷酸酶(ALP)在老年体检人群动脉粥样硬化风险评估的价值。方法:将本院体检中心2016年6月-2017年5月接收的老年体检人群346例作为研究对象,采用日本Colin公司生产的全自动动脉僵硬度自动测定仪测定baPWV,以任一侧肢体baPWV≥1737.50 cm/s定义为动脉粥样硬化,取空腹外周静脉血测定相关脂质水平、non-HDL-C及ALP水平。结果:动脉粥样硬化组的男性、糖尿病、高血压比例以及BMI、TC、TG、LDL-C、non-HDL-C、baPWV、ALP水平均显著高于非动脉粥样硬化组(P<0.05)。non-HDL-C≥4 mmol/L与<2 mmol/L比较,模型1(未校正任何因素)、模型2(校正年龄、性别、BMI因素后)、模型3(校正年龄、性别、糖尿病、高血压、BMI、TC、TG、HDL-C、LDL-C因素,评价non-HDL-C与动脉粥样硬化则剔除ALP,评价ALP则剔除non-HDL-C,OR分别为2.286(1.308,3.128)、1.893(1.302,2.817)、1.682(1.249,2.685);ALP≥90 U/L与<60 U/L比较,在模型1、模型2、模型3下OR分别为2.985(2.182,4.620)、2.618(1.486,4.428)及1.796(1.281,4.022)。结论:血清non-HDL-C及ALP是老年体检人群动脉粥样硬化的独立危险因子。
【关键词】 非高密度脂蛋白; 碱性磷酸酶; 老年体检人群; 动脉粥样硬化; 风险评估
The Value of Non-high Density Lipoprotein Combined with Alkaline Phosphatase in Risk Assessment of Atherosclerosis in Elderly Patients/ZHANG Li-fen,YU Bing-bing,ZHONG Yu-yu.//Medical Innovation of China,2017,14(27):045-048
【Abstract】 Objective:To investigate the value of non-high density lipoprotein (non-HDL-C) combined with alkaline phosphatase (ALP) in the risk assessment of atherosclerosis in elderly patients.Method:A total of 346 cases of elderly physical examination were collected from June 2016 to May 2017 in our hospital,the baPWV was measured by automatic arterial stiffness tester manufactured by Colin Company in Japan,baPWV≥1737.50 cm/s was defined as atherosclerosis,and fasting peripheral venous blood was used to determine the level of lipid,non-HDL-C and ALP.Result:The proportion of men with diabetes mellitus,hypertension,atherosclerosis and the levels of BMI,TC,TG,LDL-C,non-HDL-C,baPWV and ALP in atherosclerosis group were significantly higher than those in non-atherosclerosis group(P<0.05). non-HDL-C≥4 mmol/L and less than 2 mmol/L,model 1(not any correction factor),model 2 (adjusted for age,gender,BMI factors),model 3(adjusted for age,sex,diabetes,hypertension,BMI,TC,TG,HDL-C,LDL-C,non-HDL-C and evaluation of atherosclerosis was eliminated ALP,the evaluation of ALP eliminates non-HDL-C,OR were 2.286(1.308,3.128),1.893(1.302,2.817),and 1.682(1.249,2.685);comparison of ALP≥90 U/L and in less than 60 U/L,model 1,model 2,model 3,OR were 2.985(2.182,4.620),2.618 (1.486,4.428) and 1.796(1.281,4.022).Conclusion:Serum non-HDL-C and ALP are independent risk factors for atherosclerosis in elderly patients.
【Key words】 Non-high density lipoprotein; Alkaline phosphatase; Elderly physical examination population; Atherosclerosis; Risk assessmentendprint
First-authors address:Jiangmen Central Hospital,Jiangmen 529000,China
doi:10.3969/j.issn.1674-4985.2017.27.013
目前,临床上对动脉僵硬程度评估方法较多,如脉搏波传导速度(pulse wave velocity,PWV)、声技术测定大动脉弹性、平面压力法测定反射波增强指数(augmentation index,AI)、肱-踝脉搏波传导速度(brachial-ankle pulse wave velocity,ba-PWV)、磁共振血管成像等[1-2]。文献[3]研究发现,高脂蛋白血症是动脉粥样硬化的重要危险性因素,低密度脂蛋白胆固醇(LDL-C)增高是冠心病的重要脂类风险因素,但单一的血脂成分异常在评价动脉粥样硬化效果较差,相关性不明显,且相关性受到TG水平的影响。近年来,有学者提出,以非高密度脂蛋白(non-HDL-C)作为调脂的第二目标[4]。文献[5]报道显示,non-HDL-C水平与冠状动脉病变分支数量呈正相关性。碱性磷酸酶(ALP)是一种可将对应底物去磷酸化的糖蛋白酶,是体内磷酸盐代谢的关键酶,可作为肝胆疾病、骨骼疾病及新生儿黄疸的诊断指标。文献[6]研究发现,ALP与糖尿病、高血压、脂肪肝、外周血管病变、脂质代谢紊乱密切相关。……
